Clinical trial
Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen…
NCT00336934 · Roll International Corporation, Industry · Completed
Key facts
| NCT number | NCT00336934 |
|---|---|
| Title | Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of The Effects of Pomegranate Extract On Rising Prostate-Specific Antigen Levels In Men Following Primary Therapy |
| Lead sponsor | Roll International Corporation, Industry |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Other |
| Interventions | pomegranate juice, placebo |
| Enrollment | 183 |
| Start date | Nov 1, 2005 |
| Primary completion | Jul 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jun 15, 2006 |
| Last update posted | Aug 15, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: